Vitamin K1 Antagonisation is not Safe in High Thromboembolic Risk Patients with Over-anticoagulation

Therapies - Tập 69 - Trang 251-252 - 2014
Sébastien Champion1, Cédric Cleophax1, Sebastian Voicu1,2, Marc Sirol2, Nicolas Deye1, Frédéric J. Baud1
1Réanimation médicale et toxicologique, Hôpital Lariboisière, Paris, France
2Cardiologie, Hôpital Lariboisière, Paris, France

Tài liệu tham khảo

Pernod, 2010, French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding), Thromb Res, 126, e167, 10.1016/j.thromres.2010.06.017 Crowther, 2009, Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial, Ann Intern Med, 150, 293, 10.7326/0003-4819-150-5-200903030-00005 Ageno, 2005, A randomized trial comparing 1mg of oral vitamin K with no treatment in the management of warfarin-associated coagulopathy in patients with mechanical heart valves, J Am Coll Cardiol, 46, 732, 10.1016/j.jacc.2005.05.022 Hanslik, 2001, Vitamin K in anticoagulation therapy, Lancet, 357, 637, 10.1016/S0140-6736(05)71429-X